|
【结 构 式】 
|
【分子编号】64795 【品名】 【CA登记号】 |
【 分 子 式 】C37H60ClO8P 【 分 子 量 】699.305062 【元素组成】C 63.55% H 8.65% Cl 5.07% O 18.3% P 4.43% |
与该中间体有关的原料药合成路线共 1 条
合成路线1
该中间体在本合成路线中的序号：(V)Reaction of campestanol (I) with phosphorus oxychloride and pyridine gives the dichlorophosphoryl compound (II). Ascorbic acid (III) is protected as the 5,6-isopropylidene ketal (IV) upon treatment with acetone and fuming sulfuric acid. Condensation of (IV) with acid chloride (II) provides the phosphoryl monochloride (V), which is hydrolyzed under acidic conditions to yield the phosphate diester (VI). Finally, compound (VI) is converted to the target disodium salt by using an ethanolic solution of NaOMe. (1,2)
| 【1】 Novak, E.; Milanova, R.K.; Kutney, J.P.; Pritchard, H.P.; Lukic, T. (Forbes Medi-Tech Inc.); Novel structures comprising phytosterol and/or phytostanol and ascorbic acid and use thereof as weight regulating agents. WO 0234241 . |
| 【2】 Chen, H.; Milanova, R.K.; Kutney, J.P.; Hou, D.; Ding, Y. (Forbes Medi-Tech Inc.); Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease. JP 2003522124; WO 0100653 . |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (I) | 64792 | Campestanol; (3S,5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-17-[(1R,4R)-1,4,5-trimethylhexyl]hexadecahydro-1H-cyclopenta[a]phenanthren-3-ol | C28H50O | 详情 | 详情 | |
| (II) | 64793 | C28H49Cl2O2P | 详情 | 详情 | ||
| (III) | 29820 | (5R)-5-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2(5H)-furanone | 50-81-7 | C6H8O6 | 详情 | 详情 |
| (IV) | 64794 | (5R)-5-[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]-3,4-dihydroxy-2(5H)-furanone | C9H12O6 | 详情 | 详情 | |
| (V) | 64795 | C37H60ClO8P | 详情 | 详情 | ||
| (VI) | 64796 | (5R)-5-[(1S)-1,2-dihydroxyethyl]-4-hydroxy-2-oxo-2,5-dihydro-3-furanyl (3S,5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-17-[(1R,4R)-1,4,5-trimethylhexyl]hexadecahydro-1H-cyclopenta[a]phenanthren-3-yl hydrogen phosphate | C34H57O9P | 详情 | 详情 |
Extended Information